Estrogen and Progesterone receptors in breast malignancy – their expression and correlation with histologic parameters in southern India

Divya Lekha Gunta, N Bharata Rao


Breast carcinoma is the most common malignancy among South Indian women. Hormone receptor evaluation has become crucial for management of breast cancer. Very few studies have correlated estrogen receptors (ER) and progesterone receptors (PR) with histologic parameters in Andhra Pradesh state of Southern India therefore the study was undertaken and It is also to study the importance  IHC evaluation of ER and PR status. To evaluate  and conclude the importance of  MBR grading in a routine investigation for prognosis and prediction of clinical outcomes.

Full Text:



Tanuja Shet, Atin Agarwal, Mandar Nandkarni et all dept of path surg oncology Mumbai; "Hormone receptor s over last 8 years in a cancer referral center” IAJPM june 2009.

Pankaj Taneja, Dejan Maglic, Fumitake Kai, Sinan Zhu, Robert D. Kendig, Elizabeth A. Fry, and Kazushi Inoue " Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance".

Pertschuk LP, Kim DS, Nayer K, et al. Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival. Cancer. 1990;66: 1663–70.

Elledge RM, Green S, Pugh R, et al. Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study. Int J Cancer. 2000;89:111–7.

Hawkins RA. How best to express oestrogen receptor activity. Eur J Cancer. 2000;36(Suppl 4):S21–3.

Umekita Y, Yoshida H. Immunohistochemical study of hormone receptor and hormone-regulated protein expression in phyllodes tumor: comparison with fibroadenoma. Virchows Arch. 1998;433(4):311–4.

Fletcher CDM. Diagnostic Histopathology of Tumors. 3rd ed. Philadelphia: Churchill Livingstone; 2007.

Takashima T, Onoda N, Ishikawa T, Ogawa Y, Kato Y, Fujimoto Y, Sowa M, Hirakawa K. Prognostic value of combined analysis of estrogen receptor status and cellular proliferative activity in breast cancer patients with extensive lymph mode metastases. Oncol Rep. 2001;9:589–94.

12. Chow IW, Ho P. Hormonal receptor determination of 1,052 Chinese breast cancers. J Surg Oncol.2000;75:172–5.

13. Bozcuk H, Uslu G, Peştereli E, Samur M, Ozdoğan M, Karaveli S, Sargin F, Savaş B. Predictors of distant metastasis at presentation in breast cancer: a study also evaluating associations among common biological indicators. Breast Cancer Res Treat. 2001;68:239–48.

Allemani C, Sant M, Berrino F, et al. Prognostic value of morphology and hormone receptor status in breast cancer – a population-based study. Br J Cancer. 2004;91: 1263–8.

Wells CA, Sloane JP, Coleman D, Munt C, Amendoeira I, Apostolikas N, et al . Consistency of staining and reporting of oestrogen receptor immunohistochemistry within the Europian Union: An inter-laboratory study. Virchows Arch 2004;445:119-28.

Umemura S, Kurosumi M, Moriya T et al. Immunohistochemical evaluation forhormone receptors in breast cancer: a pratically useful evaluation system and handling protocol. Breast cancer 2006; 1: 232- 235

Desai SB, Moonim MT, Gill AK, Punia RS, Naresh KN, Chinoy RF. Hormone receptor status of breast cancer in India: a study of 798 tumors. Breast 2000;9:267-70.

Shushan Shweta J , Kusuma , Geethamani I, immunohistochemistry for ER/PR and HER2/neu in breast ccarcinomas – their relationship and association with histopathologial grading and clinical parameters in international Journal of Medical& Applied Sciences ISSN:2320‐3137.

Zafrani B, Aubriot M, Cremoux P, Rycke Y, Nicolas A, Boudou E et al. High sensitivity and specifying of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases. Hisopathology 2000; 37:536-45.

Pathak TB , Bashyal R , Pun CB , Shrestha S , Bastola S , Neupane S , Poudel BR, Lee MC : Estrogen and progesterone receptor expression in breast carcinoma Journal of Pathology of Nepal (2011) vol 1 100- 103.

Onitilo AA, Engel MJ, Greenlee TR, Mukesh NB. Breast Cancer subtypes based on ER/PR and HER-2 expression: Comparison of Clinico-pathologic features and survival. Clinical Medicine and Research; 7; 4-13.

Rakha EA, El- Sayed M E, Green A R et al: Biological and clinical characteristics of breast cancer with single hormone receptor – positive phenotype. Journal of Clinical Oncology 25:4772-4778, 2007.

Potemski P, Kusińska R, Kubiak R, et al. The predictive value and prognostic significance of the degree of expression of steroid receptors in breast cancer operation. Oncol Pol. 2007;10:49–54.

R. Kim, M. Kaneko, K. Arihiro, M. Emi, K. Tanabe, S. Murakami et al Extranuclear expression of hormone receptors in primary breast cancer. Annals of Oncology 2006; 17: 1213-1220.

Dunnwald KL, Rossing AM, ChristopherI. Hormone receptor status, tumor characteristics, and prognosis a prospective cohort of breast cancer patients. Breast cancer research 2007; 9.

Fisher ER, Redmond CK, Liu H, Rockette H, Fisher B. Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer. Cancer. 1980;45:349–53. [PubMed]

Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG. Hormone – related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol. 2000;151(7):703–14. [PubMed]

Fatima S, Faridi N, Gill S. Breast cancer: steroid receptors and other prognostic indicators. J Coll Physicians Surg Pak. 2005;15(4):230–3. [PubMed]

Rosenberg LU, Einarsdo´ ttir K, Friman EI, Wedren S, Dickman PW, Hall P, et al. Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2482–8. [PubMed]

Thike AA, Chng MJ, Fook-Chong S, Tan PH. Immunohistochemical expression of hormone receptors in invasive breast carcinoma: correlation of results of H-score with pathological parameters. Pathology. 2001;33(1):21–5.

Pathak TB , Bashyal R , Pun CB , Shrestha S , Bastola S , Neupane S , Poudel BR, Lee MC : Estrogen and progesterone receptor expression in breast carcinoma Journal of Pathology of Nepal (2011) vol 1 100- 103.

Mudduwa LK. Quick score of hormone receptor status of breast carcinoma: correlation with other clinicopathological prognostic parameters. Indian J Pathol Microbiol. 2009;52:159–63.

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

Print ISSN: 2347-6192

Online ISSN: 2347-6206